Resmed (RSMDF) Current Leases (2019 - 2026)

Resmed has reported Current Leases for 8 years, with the latest figure at $29.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 1.68% year-over-year to $29.2 million; the trailing twelve-month figure through Mar 2026 stood at $29.2 million (up 1.68% YoY), and the FY2025 full-year result was $30.5 million, up 20.68% from the prior year.
• Current Leases for Q1 2026 stood at $29.2 million, down from $29.8 million in the prior quarter.
• The five-year high for Current Leases was $30.5 million in Q2 2025, with the low at $21.1 million in Q3 2022.
• Historically, Current Leases has averaged $25.5 million across 5 years, with a median of $24.2 million in 2024.
• Annual changes were most pronounced in 2022 — Current Leases dropped 8.04% — and 2024, when it rose 29.75%.
• Resmed's Current Leases stood at $22.4 million in 2022, then rose by 7.26% to $24.1 million in 2023, then climbed by 15.61% to $27.8 million in 2024, then rose by 7.0% to $29.8 million in 2025, then fell by 1.77% to $29.2 million in 2026.
• The last three Current Leases figures came in at $29.2 million (Q1 2026), $29.8 million (Q4 2025), and $30.0 million (Q3 2025), per Business Quant data.